Skip to main content
OpenTrials

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,143 public trials 76 recruiting studies
Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection.

NCT02625909

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Kirketon Road Centre Sydney, New South Wales, Australia
  • St. Vincent's Hospital Sydney, New South Wales, Australia
View all 25 locations
View Trial Details
Completed

Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)

NCT00078403

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +18 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • University of Southern California CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford AIDS Clinical Trials Unit CRS Palo Alto, California, United States
View all 37 locations
View Trial Details
Completed

Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

NCT01482767

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +17 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • University of Southern California CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford AIDS Clinical Trials Unit CRS Palo Alto, California, United States
View all 43 locations
View Trial Details
Completed

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

NCT00991289

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +19 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford AIDS Clinical Trials Unit CRS Palo Alto, California, United States
  • UCSD Antiviral Research Center CRS San Diego, California, United States
View all 18 locations
View Trial Details
Completed

Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected Adults

NCT01165359

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Ucsd, Avrc Crs San Diego, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
View Trial Details

Related conditions